Lipid-lowering agent

Mar 18, 2020

Global Cholesterol-Lowering Drugs Markets to 2027 - Includes Company Overviews, Financials, Recent Developments, and SWOT Analyses of Key Players

Mar 18, 2020

Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy

Mar 03, 2020

Cholesterol Lowering Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Oct 24, 2019

Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020

Sep 30, 2019

"Good" Cholesterol Counters Atherosclerosis in Mice with Diabetes

Sep 13, 2018

Hyperlipidemia Drugs Market Worth $22.6 Billion by 2022 | CAGR: 2.3%: Grand View Research, Inc.

Aug 29, 2018

Lower Cholesterol Treatment Breakthrough

Mar 23, 2018

Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes

Sep 04, 2017

Global Cholesterol-lowering Drugs Market 2017-2027

May 31, 2017

Atonomics Announces CE Marking of Trace Lipids Test Panel